ClinicalTrials.gg
CompletedNCT05278884Updated Nov 17, 2022

Can VAST Improve ACLS in Rwanda

An interventional study of Advanced Cardiac Life Support Training and Vital Anesthesia Simulation Training in Global Health, Education and Resuscitation, sponsored by University of Toronto. Completed at 1 site in Rwanda. Per ClinicalTrials.gov, last updated 2022-11-17.

Sponsored by University of Toronto · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
47
Allocation
Not applicable
Sex
All
01

Study summary

Aim The purpose of this study is to determine if the addition of the VAST Course to technical resuscitation skills training enhances healthcare providers' resuscitation performance in a resource-limited setting.

Objectives

The aims of this research will be achieved by meeting the following objectives:

  1. Quantitative evaluation of study participants' resuscitation performance during a simulation scenario before ACLS course, immediately following ACLS course, immediately following VAST course, and at 4 months post training.
  2. Qualitative exploration of the barriers and supports identified by course participants to implementing resuscitation in the workplace after resuscitation skills training through focus groups.

New knowledge Lessons learned from this study will help inform the design and the implementation of resuscitation training programs in resource-limited settings. This has potential to improve resuscitation capacity in resource-limited settings leading to higher quality of care for patients.

02

Conditions studied

  • Global Health
  • Education
  • Resuscitation
03

In context

Lead sponsor

University of Toronto is the lead sponsor of 403 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full course participation
  • Available for focus group interviews

Exclusion criteria

Exclusion Criteria:

  • Refusal to provide informed consent
  • Participated in VAST or ACLS training in the four months prior to study
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
47 participants (actual)

Study arms

  • Experimental
    ACLS and then VAST teaching intervention

    For each hospital, the intervention will be to pair a 2-day technical resuscitation skills training adapted from the ACLS/AHA and a 3-day VAST course for a multidisciplinary team of 20 participants (i.e., nurses, doctors, non-physician anesthesia providers). Participants' resuscitation skills will be tested at 4 time points: immediately before the ACLS course, immediately after the ACLS course, immediately after the VAST Course, and at 4 months post training.

    Behavioral: Advanced Cardiac Life Support Training · Behavioral: Vital Anesthesia Simulation Training

Interventions

  • BehavioralAdvanced Cardiac Life Support Training

    Advanced Cardiovascular Life Support (ACLS) is a resuscitation course to teach recognition and treatment of cardiopulmonary arrest in patients.

  • BehavioralVital Anesthesia Simulation Training

    The Vital Anesthesia Simulation Training (VAST) Course focuses on core clinical practices and non-technical skills needed to respond to the most common urgent and emergent clinical challenges found in hospitals in resource-limited settings like Rwanda.

06

What researchers measure

Primary outcomes

  1. Time to initiation of CPR

    The time it takes for the team to start chest compressions in the simulation in seconds

    Time frame: From start of simulation scenario to time of first chest compressions, assessment up to 2 minutes of simulation

Secondary outcomes

  1. Time to epinephrine administration

    The time it takes for the team to give epinephrine in the simulation in seconds

    Time frame: From start of simulation scenario to time of first epinephrine administration, assessment up to 5 minutes of simulation

  2. Time to defibrillation

    The time it takes for the team to defibrillate in the simulation in seconds

    Time frame: From start of simulation scenario to time of first defibrillation, assessment up to 5 minutes of simulation

07

Study locations

1 site
  • University of Rwanda
    Kigali, Rwanda
08

References and documents

Publications

  • Tuyishime E, Mossenson A, Livingston P, Irakoze A, Seneza C, Ndekezi JK, Skelton T. Resuscitation team training in Rwanda: A mixed method study exploring the combination of the VAST course with Advanced Cardiac Life Support training. Resusc Plus. 2023 Jun 16;15:100415. doi: 10.1016/j.resplu.2023.100415. eCollection 2023 Sep. PubMed 37363124 ↗

Individual participant data

Plan to share: No — Final results will be prepared for publication but no plan to share IPD

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2022 to primary completion in Jul 2022, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2022
First posted
Mar 14, 2022
StartActual
May 1, 2022
Primary completionActual
Jul 1, 2022
CompletionActual
Oct 1, 2022
Last update
Nov 17, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05278884
Collaborators
University of Rwanda, ANZCA Health Equity Project
Responsible party
Teresa Skelton (Anesthesiologist, Assistant Professor, University of Toronto) — Principal investigator
First posted
Mar 14, 2022
Start date
May 1, 2022
Primary completion
Jul 1, 2022
Completion
Oct 1, 2022
Last update
Nov 17, 2022

Study contacts

Teresa Skelton, MD, FRCPC
principal investigator · University of Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion